Risk of Neurological Adverse Events during Tumour Necrosis FactorInhibitor Treatment for Arthritis:: A Population-Based Cohort Study from Danbio and the Danish National Patient Registry

Lene Dreyer; Tine Iskov Kopp; Rikke Kart Jacobsen; Melinda Magyari; Else Helene Ibfelt; Henning Locht; Finn Thorup Sellebjerg; Dorte Vendelbo Jensen; Rene Cordtz

doi:10.1002/art.40700

Risk of Neurological Adverse Events during Tumour Necrosis FactorInhibitor Treatment for Arthritis: A Population-Based Cohort Study from Danbio and the Danish National Patient Registry

Lene Dreyer, Tine Iskov Kopp, Rikke Kart Jacobsen, Melinda Magyari, Else Helene Ibfelt, Henning Locht, Finn Thorup Sellebjerg, Dorte Vendelbo Jensen, Rene Cordtz

Research output: Contribution to journal › Journal article › Research › peer-review

Abstract

Original language	English
Journal	Arthritis & Rheumatology
Volume	70
Issue number	Suppl. 9
Pages (from-to)	3329
ISSN	2326-5191
DOIs	https://doi.org/10.1002/art.40700
Publication status	Published - 1 Sept 2018
Event	The American College of Rheumatology, ACR/ARHP Annual Meeting - Chicago, IL, United States Duration: 19 Oct 2018 → 24 Oct 2018

Conference

Conference	The American College of Rheumatology, ACR/ARHP Annual Meeting
Country/Territory	United States
City	Chicago, IL
Period	19/10/2018 → 24/10/2018

Bibliographical note

Abstract no. 2955

Access to Document

10.1002/art.40700

AUB Link

Search for the material in Aalborg University Library's search engine

Cite this

Dreyer, L., Kopp, T. I., Jacobsen, R. K., Magyari, M., Ibfelt, E. H., Locht, H., Sellebjerg, F. T., Jensen, D. V., & Cordtz, R. (2018). Risk of Neurological Adverse Events during Tumour Necrosis FactorInhibitor Treatment for Arthritis: A Population-Based Cohort Study from Danbio and the Danish National Patient Registry. Arthritis & Rheumatology, 70(Suppl. 9), 3329. https://doi.org/10.1002/art.40700

@article{7e2cf6bb032947cdb6f5e6126c9dc324,

title = "Risk of Neurological Adverse Events during Tumour Necrosis FactorInhibitor Treatment for Arthritis:: A Population-Based Cohort Study from Danbio and the Danish National Patient Registry",

author = "Lene Dreyer and Kopp, {Tine Iskov} and Jacobsen, {Rikke Kart} and Melinda Magyari and Ibfelt, {Else Helene} and Henning Locht and Sellebjerg, {Finn Thorup} and Jensen, {Dorte Vendelbo} and Rene Cordtz",

note = "Abstract no. 2955; The American College of Rheumatology, ACR/ARHP Annual Meeting ; Conference date: 19-10-2018 Through 24-10-2018",

year = "2018",

month = sep,

day = "1",

doi = "10.1002/art.40700",

language = "English",

volume = "70",

pages = "3329",

journal = "Arthritis & Rheumatology",

issn = "2326-5191",

publisher = "Wiley",

number = "Suppl. 9",

}

Dreyer, L, Kopp, TI, Jacobsen, RK, Magyari, M, Ibfelt, EH, Locht, H, Sellebjerg, FT, Jensen, DV & Cordtz, R 2018, 'Risk of Neurological Adverse Events during Tumour Necrosis FactorInhibitor Treatment for Arthritis: A Population-Based Cohort Study from Danbio and the Danish National Patient Registry', Arthritis & Rheumatology, vol. 70, no. Suppl. 9, pp. 3329. https://doi.org/10.1002/art.40700

Risk of Neurological Adverse Events during Tumour Necrosis FactorInhibitor Treatment for Arthritis: A Population-Based Cohort Study from Danbio and the Danish National Patient Registry. / Dreyer, Lene; Kopp, Tine Iskov; Jacobsen, Rikke Kart et al.
In: Arthritis & Rheumatology, Vol. 70, No. Suppl. 9, 01.09.2018, p. 3329.

Research output: Contribution to journal › Journal article › Research › peer-review

TY - JOUR

T1 - Risk of Neurological Adverse Events during Tumour Necrosis FactorInhibitor Treatment for Arthritis:

T2 - The American College of Rheumatology, ACR/ARHP Annual Meeting

AU - Dreyer, Lene

AU - Kopp, Tine Iskov

AU - Jacobsen, Rikke Kart

AU - Magyari, Melinda

AU - Ibfelt, Else Helene

AU - Locht, Henning

AU - Sellebjerg, Finn Thorup

AU - Jensen, Dorte Vendelbo

AU - Cordtz, Rene

N1 - Abstract no. 2955

PY - 2018/9/1

Y1 - 2018/9/1

UR - http://www.scopus.com/inward/record.url?scp=85055074367&partnerID=8YFLogxK

U2 - 10.1002/art.40700

DO - 10.1002/art.40700

M3 - Journal article

SN - 2326-5191

VL - 70

SP - 3329

JO - Arthritis & Rheumatology

JF - Arthritis & Rheumatology

IS - Suppl. 9

Y2 - 19 October 2018 through 24 October 2018

ER -